Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Runxia Gu"'
Autor:
Huan Li, Zhijie Cao, Yiming Liu, Zhenya Xue, Yishuang Li, Haiyan Xing, Yingxi Xu, Runxia Gu, Shaowei Qiu, Hui Wei, Min Wang, Qing Rao, Jianxiang Wang
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2554-2568 (2024)
Persistence of quiescent leukemia stem cells (LSCs) after treatment most likely contributes to chemotherapy resistance and poor prognosis of leukemia patients. Identification of this quiescent cell population would facilitate eradicating LSCs. Here,
Externí odkaz:
https://doaj.org/article/02a4fc700d8748e999d62317f088c4b8
Autor:
Yu Liu, Wenbing Liu, Anli Lai, Yihan Mei, Ying Wang, Hui Wei, Qing Rao, Runxia Gu, Yingchang Mi, Min Wang, Jianxiang Wang, Shaowei Qiu
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/8a96ff2f3a5d49fca39cb9954baadc13
Autor:
Yihan Mei, Yu Liu, Wenbing Liu, Manling Chen, Xiaoyu Liu, Shangshang Wang, Junli Mou, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Runxia Gu, Shaowei Qiu, Jianxiang Wang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-15 (2024)
Abstract Besides chemotherapy and hematopoietic stem cell transplantation (HSCT), autologous T cells can also serve as a new treatment approach for AML patients. However, the features of tumor-reactive T cells and their distinctive markers still lack
Externí odkaz:
https://doaj.org/article/e97357d17ad2400eafbb3881b7f30d9b
Autor:
Anli Lai, Wenbing Liu, Hui Wei, Ying Wang, Dong Lin, Chunlin Zhou, Bingcheng Liu, Runxia Gu, Yan Li, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Junping Zhang, Yingchang Mi, Jianxiang Wang, Shaowei Qiu
Publikováno v:
Blood Science, Vol 6, Iss 2, p e00188 (2024)
Acute myeloid leukemia (AML) with t(16;21)(p11;q22)/FUS::ERG is a rare AML subtype associated with poor prognosis. However, its clinical and molecular features remain poorly defined. We determined the clinicopathological, genomic, and transcriptomic
Externí odkaz:
https://doaj.org/article/8eb5384dcf3d4bcd8bb6654f1fe034de
Autor:
Manling Chen, Xiaoyu Liu, Nan Peng, Ting Zhang, Junli Mou, Huizhen He, Ying Wang, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-15 (2023)
Abstract Background T cell-redirecting bispecific antibodies establish a connection between endogenous T cells and tumor cells, activating T cells function to eliminate tumor cells without ex vivo genetic alteration or manipulation. Here, we develope
Externí odkaz:
https://doaj.org/article/a8de11f0d8204d7eb910c2b4238de5a4
Autor:
Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Several international centers have used and reported pediatric-inspired regimens for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL). However, there is a lack of prospective data on the Chine
Externí odkaz:
https://doaj.org/article/5368f216a37841fba86dc648fd00a3eb
Autor:
Runxia Gu, Fang Liu, Dehui Zou, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Huijun Wang, Hui Wei, Yingchang Mi, Lugui Qiu, Lulu Lv, Min Wang, Ying Wang, Xiaofan Zhu, Jianxiang Wang
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-13 (2020)
Abstract Background Recent evidence suggests that resistance to CD19 chimeric antigen receptor (CAR)-modified T cell therapy may be due to the presence of CD19 isoforms that lose binding to the single-chain variable fragment (scFv) in current use. As
Externí odkaz:
https://doaj.org/article/43e85b5125774556b2159320d58d13d5
Autor:
Qiuyun Fang, Yang Song, Xiaoyuan Gong, Jun Wang, Qinghua Li, Kaiqi Liu, Yahui Feng, Qishan Hao, Yan Li, Hui Wei, Guangji Zhang, Yuntao Liu, Benfa Gong, Ying Wang, Chunlin Zhou, Dong Lin, Bingcheng Liu, Shuning Wei, Runxia Gu, Yingchang Mi, Jianxiang Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although pediatric-like treatment regimen has remarkably improved the survival rates of adults with acute lymphoblastic leukemia (ALL), the outcome of some adult patients is still poor owing to adverse genetic features. These molecular abnormalities,
Externí odkaz:
https://doaj.org/article/8b11e5fa305844a9848efb0dd7b5de5e
Autor:
Hui Wei, Chunlin Zhou, Dong Lin, Bingcheng Liu, Yan Li, Xingli Zhao, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Jiayuan Chen, Junping Zhang, Jingjing Jin, Shaowei Qiu, Runxia Gu, Ying Wang, Yingchang Mi, Jianxiang Wang
Publikováno v:
Haematologica, Vol 106, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/08ee91ca579c45e7ae05c6b282362712
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-8 (2018)
Abstract For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous l
Externí odkaz:
https://doaj.org/article/50aa8a33d82e4342ac26dabda751e30f